Wilson's Disease: When Copper Poisons Your Liver

Wilson's disease is a rare genetic disorder in which your body can't properly excrete copper — causing it to accumulate in your liver, brain, eyes, and other organs. The liver is typically the first organ affected: copper deposits trigger chronic inflammation, fibrosis, and can progress to cirrhosis — sometimes rapidly. In some patients, copper also deposits in the brain, causing psychiatric symptoms (personality changes, depression, psychosis) and neurological problems (tremor, difficulty walking, speech impairment) that can be the presenting features of the disease.

Wilson's disease is rare — affecting approximately 1 in 30,000 people — but diagnosing it matters enormously because it's one of the few liver diseases where early treatment can completely prevent organ damage. Untreated, Wilson's disease is fatal. Treated, patients can live normal lifespans. The challenge is thinking to look for it.

What's happening inside your body

Copper is an essential trace mineral — you need small amounts for enzyme function, nerve signaling, and iron metabolism. In healthy people, the liver processes dietary copper, incorporates it into a transport protein called ceruloplasmin, and excretes the excess into bile (which carries it out of the body through the intestines). This excretory mechanism keeps copper levels in balance.

In Wilson's disease, a mutation in the ATP7B gene (inherited in an autosomal recessive pattern — you need two copies, one from each parent) disrupts the liver's ability to incorporate copper into ceruloplasmin AND excrete it into bile. Copper enters the body normally through food but can't leave. It accumulates — first in the liver, then overflows into the bloodstream and deposits in the brain, eyes (Kayser-Fleischer rings), kidneys, and other organs.

The liver damage progresses through inflammation → fibrosis → cirrhosis, following the same pathway as other chronic liver diseases but often at an accelerated pace. Some patients present with acute liver failure — a sudden, catastrophic release of copper from a saturated liver into the bloodstream, causing massive hepatocyte death, hemolytic anemia (copper destroys red blood cells), and multi-organ failure.

When to suspect Wilson's disease

Wilson's disease typically presents between ages 5 and 35 — though it can present later. The presentation varies dramatically:

Hepatic presentation (most common in children and adolescents)

Ranges from asymptomatic elevated liver enzymes found on routine blood work to chronic hepatitis mimicking viral or autoimmune hepatitis, to established cirrhosis, to fulminant (acute) liver failure. Wilson's should be considered in any young person with unexplained liver disease — especially if autoimmune hepatitis markers are negative and viral hepatitis has been ruled out.

Neuropsychiatric presentation (more common in teens and young adults)

Tremor (often an asymmetric action tremor), difficulty with handwriting, slurred speech (dysarthria), difficulty walking (gait abnormalities), personality changes (irritability, disinhibition, impulsivity), depression, anxiety, and in severe cases, psychosis. These neurological symptoms can precede any recognized liver disease — leading to years of psychiatric treatment before someone thinks to check the liver.

Kayser-Fleischer rings

Golden-brown rings visible at the outer edge of the cornea — caused by copper deposition in Descemet's membrane of the eye. Visible on slit-lamp examination (by an ophthalmologist) and present in approximately 95% of patients with neuropsychiatric Wilson's and 50–60% of patients with hepatic Wilson's. Their presence is highly suggestive of Wilson's disease but their absence doesn't rule it out.

Diagnosis

No single test diagnoses Wilson's disease — the diagnosis is based on a combination of clinical findings and lab results:

The Leipzig scoring system combines multiple parameters into a probability score (0–4+ = Wilson's disease unlikely; ≥4 = diagnosis established). Most hepatologists use this system for diagnostic decision-making.

Treatment: removing the copper

Treatment is lifelong and has two phases:

Phase 1: De-coppering (initial treatment)

D-penicillamine (Cuprimine): The oldest copper chelator — binds copper and promotes its excretion in urine. Effective but has significant side effects (hypersensitivity reactions, bone marrow suppression, kidney toxicity, autoimmune complications) requiring close monitoring. Dose: 1–1.5 g/day in divided doses.

Trientine (Syprine): An alternative chelator with fewer side effects than D-penicillamine. First-line in many centers, particularly for patients who can't tolerate penicillamine. Dose: 750–1,500 mg/day in divided doses.

Both chelators are taken on an empty stomach (food reduces absorption). The de-coppering phase typically takes 6–12 months to achieve adequate copper reduction — monitored by 24-hour urine copper (initially rises as copper is mobilized, then falls as body stores deplete) and clinical improvement.

Phase 2: Maintenance

Zinc acetate (Galzin): Works by a completely different mechanism — zinc induces metallothionein in intestinal cells, which binds dietary copper and prevents its absorption. The bound copper is excreted when intestinal cells are shed. Zinc is used as maintenance therapy after initial de-coppering (or as first-line in asymptomatic or pre-symptomatic patients). Dose: 150 mg elemental zinc/day in 3 divided doses between meals. Side effect: nausea (the most common complaint — taking between meals helps). Lower chelator doses may be continued alongside zinc or used alone for maintenance — the approach varies by center and patient response.

Acute liver failure from Wilson's

Fulminant Wilson's disease — acute liver failure with massive copper release — is a medical emergency. Medical chelation alone is often insufficient. Liver transplant is the definitive treatment and is curative (the new liver has functional ATP7B and can excrete copper normally). Wilson's-related acute liver failure has the highest priority on the transplant waiting list. Post-transplant, copper metabolism normalizes and chelation therapy is no longer needed.

Living with Wilson's disease

• Medication compliance is lifelong and non-negotiable. Stopping chelation or zinc allows copper to reaccumulate — and the organ damage that follows can be irreversible, particularly neurological damage. This is one of the most treatment-responsive liver diseases when therapy is maintained — and one of the most dangerous when it's not.

• Dietary copper restriction. Avoid foods very high in copper: liver and organ meats, shellfish (especially oysters), nuts (particularly cashews and walnuts), chocolate, mushrooms, and soy products. You don't need to eliminate copper entirely (it's in most foods) — just avoid the highest-concentration sources. Your hepatologist or dietitian can provide a detailed dietary guide.

• Water testing. If your home has copper plumbing, test your water's copper content. If levels are high, use a water filter that removes copper or run the tap for 30+ seconds before drinking (first-draw water has the highest copper concentration).

• Regular monitoring. 24-hour urine copper and serum copper/ceruloplasmin every 6–12 months. Liver function tests every 3–6 months. Upload every lab report to LiverTracker. If you have established cirrhosis from Wilson's, standard cirrhosis monitoring applies — HCC screening, variceal screening, etc.

• Family screening. Wilson's is autosomal recessive — siblings of affected patients have a 25% chance of having the disease. All first-degree relatives should be screened with ceruloplasmin, liver enzymes, and 24-hour urine copper. Genetic testing of family members is recommended when the patient's mutations are known. Pre-symptomatic diagnosis allows treatment before any organ damage occurs — the best possible outcome.

• Pregnancy considerations. Chelation therapy should be continued during pregnancy at reduced doses (stopping risks copper reaccumulation). D-penicillamine is associated with rare connective tissue abnormalities in newborns — many centers switch to trientine or zinc during pregnancy. Breastfeeding is generally acceptable on zinc maintenance.

Prognosis

With early diagnosis and consistent treatment, the prognosis for Wilson's disease is excellent — patients can live normal lifespans with normal quality of life. Liver damage that hasn't progressed to cirrhosis can fully reverse with copper depletion. Neurological symptoms improve in approximately 50–70% of patients with treatment (though improvement may take months to years and isn't always complete — which is why early diagnosis before neurological involvement is ideal).

Without treatment, Wilson's disease progresses to cirrhosis, liver failure, and/or severe neuropsychiatric disability — and is ultimately fatal. The contrast between treated and untreated outcomes makes Wilson's one of the most important liver diseases to diagnose early.

Frequently asked questions

Is Wilson's disease the same as hemochromatosis?

No — though both are genetic conditions involving metal accumulation. Wilson's disease involves copper overload (from ATP7B gene mutation). Hemochromatosis involves iron overload (from HFE gene mutation). Both damage the liver but through different metals and different mechanisms. Treatment is different too: Wilson's uses chelation/zinc; hemochromatosis uses phlebotomy.

Can Wilson's disease be cured?

Liver transplant is curative (the new liver has normal copper excretion). Without transplant, Wilson's is controllable but not curable — lifelong chelation/zinc therapy is needed. Gene therapy approaches are being researched but aren't yet available.

Will I need treatment forever?

Yes. Stopping treatment allows copper to reaccumulate, and the resulting damage (particularly neurological) may be irreversible. Treatment is lifelong — but for most patients, the maintenance phase (zinc, often with reduced-dose chelation) is well-tolerated and becomes routine.

How is Wilson's disease inherited?

Autosomal recessive — you need two copies of the mutated ATP7B gene (one from each parent) to develop the disease. Carriers (one copy) don't develop clinical disease but can pass the gene to their children. If both parents are carriers, each child has a 25% chance of having Wilson's disease.

Can Wilson's disease present after age 40?

Rarely — but it's been reported in patients up to age 70. The classic presentation is between ages 5 and 35. Late presentations are more likely to be hepatic (liver disease) than neurological. Wilson's should be considered in unexplained liver disease at any age — especially if ceruloplasmin is low.

Wilson's disease is rare, treatable, and devastating when missed. If you're young with unexplained liver problems — or if someone in your family has been diagnosed — get tested. A single blood test can start you on the path to a completely preventable catastrophe.

→ Check Your Liver Enzymes Free

→ Start Tracking Free

→ Take the Liver Health Quiz

Medical Disclaimer: This article is for informational and educational purposes only. Wilson's disease management requires a hepatologist experienced in metabolic liver disease. Never stop chelation or zinc therapy without medical guidance. Visit livertracker.com/medical-disclaimer.